APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurovascular Devices

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Selected research

Market Structure

Global Neurovascular Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026187 pages

Choose your research edition.

Industry ResearchNeurovascular Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurovascular Devices Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Neurovascular Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurovascular Devices Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurovascular Devices Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.

Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.

Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.

Read the full market overview

On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.

Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.

This report provides an overview of the global Neurovascular Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurovascular Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurovascular Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurovascular Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurovascular Devices Segment by Company

Stryker Corporation

Johnson & Johnson

Medtronic

Terumo

Penumbra

Microport Scientific Corporation

Abbott Vascular

W. L. Gore & Associates

Neurovascular Devices Segment by Type

Aneurysm Coiling & Embolization Devices

Cerebral Balloon Angioplasty & Stenting Systems

Support Devices

Neurothrombectomy Devices

Neurovascular Devices Segment by Application

Hospitals

Clinics

Ambulatory Surgical Units

Neurovascular Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurovascular Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurovascular Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurovascular Devices Industry Trends Table 2. Neurovascular Devices Industry Drivers Table 3. Neurovascular Devices Industry Opportunities and Challenges Table 4. Neurovascular Devices Industry Restraints Table 5. Global Neurovascular Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurovascular Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurovascular Devices Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Neurovascular Devices Sales Market Share by Manufacturers Table 9. Global Neurovascular Devices Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Neurovascular Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurovascular Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurovascular Devices Manufacturers, Product Type & Application Table 13. Global Neurovascular Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurovascular Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Aneurysm Coiling & Embolization Devices Table 17. Major Manufacturers of Cerebral Balloon Angioplasty & Stenting Systems Table 18. Major Manufacturers of Support Devices Table 19. Major Manufacturers of Neurothrombectomy Devices Table 20. Global Neurovascular Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Neurovascular Devices Sales by Type (2021-2026) & (K Units) Table 22. Global Neurovascular Devices Sales by Type (2027-2032) & (K Units) Table 23. Global Neurovascular Devices Sales Market Share by Type (2021-2026) Table 24. Global Neurovascular Devices Sales Market Share by Type (2027-2032) Table 25. Global Neurovascular Devices Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Neurovascular Devices Revenue by Type (2021-2026) & (K Units) Table 27. Global Neurovascular Devices Revenue by Type (2027-2032) & (K Units) Table 28. Global Neurovascular Devices Revenue Market Share by Type (2021-2026) Table 29. Global Neurovascular Devices Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Clinics Table 32. Major Manufacturers of Ambulatory Surgical Units Table 33. Global Neurovascular Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Neurovascular Devices Sales by Application (2021-2026) & (K Units) Table 35. Global Neurovascular Devices Sales by Application (2027-2032) & (K Units) Table 36. Global Neurovascular Devices Sales Market Share by Application (2021-2026) Table 37. Global Neurovascular Devices Sales Market Share by Application (2027-2032) Table 38. Global Neurovascular Devices Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Neurovascular Devices Revenue by Application (2021-2026) & (K Units) Table 40. Global Neurovascular Devices Revenue by Application (2027-2032) & (K Units) Table 41. Global Neurovascular Devices Revenue Market Share by Application (2021-2026) Table 42. Global Neurovascular Devices Revenue Market Share by Application (2027-2032) Table 43. Global Neurovascular Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Neurovascular Devices Sales by Region (2021-2026) & (K Units) Table 45. Global Neurovascular Devices Sales Market Share by Region (2021-2026) Table 46. Global Neurovascular Devices Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Neurovascular Devices Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Neurovascular Devices Sales by Country (2021-2026) & (K Units) Table 50. North America Neurovascular Devices Sales by Country (2027-2032) & (K Units) Table 51. Europe Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Neurovascular Devices Sales by Country (2021-2026) & (K Units) Table 53. Europe Neurovascular Devices Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Neurovascular Devices Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Neurovascular Devices Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Neurovascular Devices Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Neurovascular Devices Sales by Country (2027-2032) & (K Units) Table 60. Global Neurovascular Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Neurovascular Devices Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Neurovascular Devices Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Neurovascular Devices Revenue Market Share by Region (2021-2026) Table 64. Global Neurovascular Devices Revenue Market Share by Region (2027-2032) Table 65. Stryker Corporation Company Information Table 66. Stryker Corporation Business Overview Table 67. Stryker Corporation Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Stryker Corporation Neurovascular Devices Product Portfolio Table 69. Stryker Corporation Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Neurovascular Devices Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Medtronic Neurovascular Devices Product Portfolio Table 79. Medtronic Recent Development Table 80. Terumo Company Information Table 81. Terumo Business Overview Table 82. Terumo Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Terumo Neurovascular Devices Product Portfolio Table 84. Terumo Recent Development Table 85. Penumbra Company Information Table 86. Penumbra Business Overview Table 87. Penumbra Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Penumbra Neurovascular Devices Product Portfolio Table 89. Penumbra Recent Development Table 90. Microport Scientific Corporation Company Information Table 91. Microport Scientific Corporation Business Overview Table 92. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Microport Scientific Corporation Neurovascular Devices Product Portfolio Table 94. Microport Scientific Corporation Recent Development Table 95. Abbott Vascular Company Information Table 96. Abbott Vascular Business Overview Table 97. Abbott Vascular Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Abbott Vascular Neurovascular Devices Product Portfolio Table 99. Abbott Vascular Recent Development Table 100. W. L. Gore & Associates Company Information Table 101. W. L. Gore & Associates Business Overview Table 102. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. W. L. Gore & Associates Neurovascular Devices Product Portfolio Table 104. W. L. Gore & Associates Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Neurovascular Devices Distributors List Table 108. Neurovascular Devices Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Neurovascular Devices Product Image Figure 2. Global Neurovascular Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurovascular Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurovascular Devices Sales (2021-2032) & (K Units) Figure 5. Global Neurovascular Devices Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurovascular Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Aneurysm Coiling & Embolization Devices Image Figure 9. Cerebral Balloon Angioplasty & Stenting Systems Image Figure 10. Support Devices Image Figure 11. Neurothrombectomy Devices Image Figure 12. Global Neurovascular Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Neurovascular Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Neurovascular Devices Sales Market Share by Type (2021-2032) Figure 15. Global Neurovascular Devices Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Neurovascular Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Neurovascular Devices Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Ambulatory Surgical Units Image Figure 21. Global Neurovascular Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Neurovascular Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Neurovascular Devices Sales Market Share by Application (2021-2032) Figure 24. Global Neurovascular Devices Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Neurovascular Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Neurovascular Devices Revenue Market Share by Application (2021-2032) Figure 27. North America Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Neurovascular Devices Sales Market Share by Country (2021-2032) Figure 29. U.S. Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Neurovascular Devices Sales Market Share by Country (2021-2032) Figure 34. Germany Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Neurovascular Devices Sales Market Share by Country (2021-2032) Figure 41. China Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Neurovascular Devices Sales Market Share by Country (2021-2032) Figure 49. Brazil Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Neurovascular Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Neurovascular Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Neurovascular Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Neurovascular Devices Revenue (2021-2032) & (US$ Million) Figure 60. North America Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Neurovascular Devices Revenue (2021-2032) & (US$ Million) Figure 62. Europe Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Neurovascular Devices Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Neurovascular Devices Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Neurovascular Devices Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Neurovascular Devices Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Aneurysm Coiling & Embolization Devices
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Support Devices
  • Neurothrombectomy Devices
Applications
  • Hospitals
  • Clinics
  • Ambulatory Surgical Units
Companies covered
  • Stryker Corporation
  • Johnson & Johnson
  • Medtronic
  • Terumo
  • Penumbra
  • Microport Scientific Corporation
  • Abbott Vascular
  • W. L. Gore & Associates

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurovascular Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurovascular Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurovascular Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurovascular Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurovascular Devices Market Dynamics
  1. 2.1 Neurovascular Devices Industry Trends
  2. 2.2 Neurovascular Devices Industry Drivers
  3. 2.3 Neurovascular Devices Industry Opportunities and Challenges
  4. 2.4 Neurovascular Devices Industry Restraints
3 Neurovascular Devices Market by Manufacturers
  1. 3.1 Global Neurovascular Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurovascular Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurovascular Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurovascular Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurovascular Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurovascular Devices Manufacturers, Product Type & Application
  7. 3.7 Global Neurovascular Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurovascular Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurovascular Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurovascular Devices Tier 1, Tier 2, and Tier 3
4 Neurovascular Devices Market by Type
  1. 4.1 Neurovascular Devices Type Introduction
  2. 4.1.1 Aneurysm Coiling & Embolization Devices
  3. 4.1.2 Cerebral Balloon Angioplasty & Stenting Systems
  4. 4.1.3 Support Devices
  5. 4.1.4 Neurothrombectomy Devices
  6. 4.2 Global Neurovascular Devices Sales by Type
  7. 4.2.1 Global Neurovascular Devices Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurovascular Devices Sales by Type (2021-2032)
  9. 4.2.3 Global Neurovascular Devices Sales Market Share by Type (2021-2032)
  10. 4.3 Global Neurovascular Devices Revenue by Type
  11. 4.3.1 Global Neurovascular Devices Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neurovascular Devices Revenue by Type (2021-2032)
  13. 4.3.3 Global Neurovascular Devices Revenue Market Share by Type (2021-2032)
5 Neurovascular Devices Market by Application
  1. 5.1 Neurovascular Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Ambulatory Surgical Units
  5. 5.2 Global Neurovascular Devices Sales by Application
  6. 5.2.1 Global Neurovascular Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurovascular Devices Sales by Application (2021-2032)
  8. 5.2.3 Global Neurovascular Devices Sales Market Share by Application (2021-2032)
  9. 5.3 Global Neurovascular Devices Revenue by Application
  10. 5.3.1 Global Neurovascular Devices Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurovascular Devices Revenue by Application (2021-2032)
  12. 5.3.3 Global Neurovascular Devices Revenue Market Share by Application (2021-2032)
6 Global Neurovascular Devices Sales by Region
  1. 6.1 Global Neurovascular Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurovascular Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Neurovascular Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Neurovascular Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurovascular Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurovascular Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurovascular Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurovascular Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurovascular Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurovascular Devices Revenue by Region
  1. 7.1 Global Neurovascular Devices Revenue by Region
  2. 7.1.1 Global Neurovascular Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurovascular Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurovascular Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurovascular Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurovascular Devices Revenue (2021-2032)
  8. 7.2.2 North America Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurovascular Devices Revenue (2021-2032)
  11. 7.3.2 Europe Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurovascular Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurovascular Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurovascular Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker Corporation
  2. 8.1.1 Stryker Corporation Company Information
  3. 8.1.2 Stryker Corporation Business Overview
  4. 8.1.3 Stryker Corporation Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Corporation Neurovascular Devices Product Portfolio
  6. 8.1.5 Stryker Corporation Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Neurovascular Devices Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Neurovascular Devices Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Neurovascular Devices Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Penumbra
  26. 8.5.1 Penumbra Company Information
  27. 8.5.2 Penumbra Business Overview
  28. 8.5.3 Penumbra Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Penumbra Neurovascular Devices Product Portfolio
  30. 8.5.5 Penumbra Recent Developments
  31. 8.6 Microport Scientific Corporation
  32. 8.6.1 Microport Scientific Corporation Company Information
  33. 8.6.2 Microport Scientific Corporation Business Overview
  34. 8.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Microport Scientific Corporation Neurovascular Devices Product Portfolio
  36. 8.6.5 Microport Scientific Corporation Recent Developments
  37. 8.7 Abbott Vascular
  38. 8.7.1 Abbott Vascular Company Information
  39. 8.7.2 Abbott Vascular Business Overview
  40. 8.7.3 Abbott Vascular Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Vascular Neurovascular Devices Product Portfolio
  42. 8.7.5 Abbott Vascular Recent Developments
  43. 8.8 W. L. Gore & Associates
  44. 8.8.1 W. L. Gore & Associates Company Information
  45. 8.8.2 W. L. Gore & Associates Business Overview
  46. 8.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 W. L. Gore & Associates Neurovascular Devices Product Portfolio
  48. 8.8.5 W. L. Gore & Associates Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurovascular Devices Value Chain Analysis
  2. 9.1.1 Neurovascular Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurovascular Devices Production Mode & Process
  6. 9.2 Neurovascular Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurovascular Devices Distributors
  9. 9.2.3 Neurovascular Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst